Cardio Diagnostics Holdings, Inc. Proceeds from Common Stock Issued
Cardio Diagnostics Holdings, Inc. (CDIO) reported Proceeds from Common Stock Issued of $103.91 thousand for the 0-month period ending 2025-07-15, per its 10-Q filed 2025-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2025-08-14
- Cardio Diagnostics Holdings, Inc. proceeds from issuance of common stock for the quarter ending 2022-12-31 was $11.99M.
- Cardio Diagnostics Holdings, Inc. proceeds from issuance of common stock for the quarter ending 2022-09-30 was $0.00.
- Cardio Diagnostics Holdings, Inc. proceeds from issuance of common stock for fiscal 2022 was $11.99M, a 970.18% increase from fiscal 2021.
- Cardio Diagnostics Holdings, Inc. proceeds from issuance of common stock for fiscal 2021 was $1.12M.
| Period end | Proceeds from Issuance of Common Stock 0 month | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 4 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 7 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|---|---|---|
| 2025-07-15 | $103.91K 10-Q · filed 2025-08-14 | |||||||
| 2022-12-31 | $11.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $11.99M derived: sum of 2 quarters · filed 2023-03-31 | $11.99M 10-K · filed 2023-03-31 | |||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 | ||||||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-10 | |||||||
| 2021-12-31 | $25.00K 10-K · filed 2022-03-31 | $1.12M 10-K · filed 2023-03-31 | ||||||
| 2021-09-30 | $25.00K 10-Q · filed 2022-11-07 | |||||||
| 2021-06-30 | $25.00K 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |